edotreotide has been researched along with Thoracic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castaldi, P; Giordano, A; Rindi, G; Rufini, V; Treglia, G | 1 |
1 review(s) available for edotreotide and Thoracic Neoplasms
| Article | Year |
|---|---|
Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.
Topics: Algorithms; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Positron-Emission Tomography; Receptors, Somatostatin; Sensitivity and Specificity; Thoracic Neoplasms; Tomography, X-Ray Computed | 2012 |